Semaglutide sustained release - Peptron
Alternative Names: PT-403Latest Information Update: 08 Aug 2023
At a glance
- Originator Peptron
- Class Antidementias; Antihyperglycaemics; Glucagon-like peptides; Hepatoprotectants; Obesity therapies; Urologics; Vascular disorder therapies
- Mechanism of Action Glucagon-like peptide-1 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Diabetes mellitus; Obesity
Most Recent Events
- 23 Jun 2023 Preclinical trials in Diabetes mellitus in South Korea (SC)
- 23 Jun 2023 Preclinical trials in Obesity in South Korea (SC)
- 23 Jun 2023 Pharmacokinetics data from a preclinical trial in diabetes mellitus and obesity presented at 83rd Annual Scientific Sessions of the American Diabetes Association (ADA-2023)